[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 13, 1952

FAILURE OF CORTICOTROPIN TO PREVENT ACUTE HEMOLYTIC ANEMIA DUE TO SULFAPYRIDINE

Author Affiliations

Honolulu, T. H.

From the departments of internal medicine and dermatology of the Straub Clinic.

JAMA. 1952;150(2):95-96. doi:10.1001/jama.1952.63680020004007b
Abstract

How sulfapyridine causes acute hemolytic anemia is not known, and the reaction can only be classed as an idiosyncrasy.1 The beneficial effect of corticotropin (ACTH) on "idiopathic" acquired hemolytic anemia has been described by Dameshek,2 Gardner,3 Davidson,4 and their co-workers. Davidson and associates also noted no significant improvement when corticotropin was given to patients with congenital hemolytic anemia. Simpson and his colleagues5 reported two cases in which corticotropin appeared to produce some improvement in patients with erythroblastosis fetalis. No account of the effect of corticotropin in acquired hemolytic anemia due to a drug has come to our attention.

REPORT OF A CASE  A 51-year-old Filipino barber consulted one of us (H. L. A.) on May 21, 1951, because of a second attack of severe dermatitis repens of the right foot complicated by infection with an organism of the coli-aerogenes group and by Pseudomonas aeruginosa intertrigo

First Page Preview View Large
First page PDF preview
First page PDF preview
×